Aging and Disease

Scope & Guideline

Connecting scholars to the future of aging research.

Introduction

Delve into the academic richness of Aging and Disease with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN2152-5250
PublisherINT SOC AGING & DISEASE
Support Open AccessYes
CountryUnited States
TypeJournal
Convergefrom 2010 to 2024
AbbreviationAGING DIS / Aging Dis.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressEDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106

Aims and Scopes

The journal 'Aging and Disease' focuses on advancing knowledge in the fields of aging and age-related diseases through a multidisciplinary approach, integrating basic science, clinical research, and therapeutic strategies.
  1. Age-Related Molecular Mechanisms:
    The journal emphasizes research on the molecular and cellular mechanisms underlying aging, including studies on oxidative stress, mitochondrial dysfunction, and cellular senescence.
  2. Chronic Diseases and Aging:
    A significant focus is placed on the relationship between aging and chronic diseases such as Alzheimer's disease, cardiovascular diseases, and diabetes, exploring their pathophysiology and potential interventions.
  3. Therapeutic Interventions and Innovations:
    The journal highlights novel therapeutic approaches and interventions aimed at mitigating age-related decline, including pharmacological treatments, stem cell therapies, and lifestyle modifications.
  4. Translational Research and Clinical Studies:
    Research that bridges the gap between laboratory findings and clinical applications is a core aspect, with studies designed to inform clinical practice for aging populations.
  5. Public Health and Aging:
    The journal also addresses public health issues related to aging, including epidemiological studies, healthcare policies, and the impact of socio-environmental factors on aging.
Recent publications in 'Aging and Disease' reveal several emerging themes that are gaining traction, indicating the direction of future research in the field.
  1. Microbiome and Aging:
    The relationship between the gut microbiome and aging is increasingly prominent, with studies exploring how microbiota influences age-related diseases and overall health.
  2. Cellular Senescence and its Implications:
    Research on cellular senescence, particularly its role in aging and chronic diseases, is rapidly expanding, highlighting its potential as a therapeutic target.
  3. Neuroinflammation and Cognitive Decline:
    There is a growing focus on the role of neuroinflammation in cognitive decline and neurodegenerative diseases, suggesting new avenues for intervention.
  4. Machine Learning and AI in Aging Research:
    The integration of machine learning and artificial intelligence in analyzing aging-related data is emerging as a critical area, promising to enhance predictive models and therapeutic strategies.
  5. Interdisciplinary Approaches to Aging:
    An increase in interdisciplinary studies that combine insights from genetics, epigenetics, neuroscience, and public health reflects a holistic view of aging research.

Declining or Waning

While 'Aging and Disease' continues to grow in various areas, some themes have shown a decline in prominence, reflecting shifts in research interests and funding.
  1. Traditional Pharmacological Approaches:
    There is a notable decrease in studies focusing solely on traditional pharmacological interventions without considering holistic or integrative approaches to aging.
  2. Basic Animal Models:
    Research utilizing basic animal models for aging studies has waned, with a shift towards more complex models that better mimic human aging and diseases.
  3. Isolated Studies on Single Age-Related Diseases:
    The journal has seen fewer publications that isolate studies on single diseases, as there is a growing trend towards understanding multi-morbidity and the interconnectedness of age-related conditions.

Similar Journals

npj Aging and Mechanisms of Disease

Unraveling the Secrets of Aging and Disease
Publisher: NATURE PORTFOLIOISSN: Frequency: 1 issue/year

npj Aging and Mechanisms of Disease is a leading open-access journal dedicated to advancing the understanding of the biological mechanisms underlying aging and age-related diseases. Published by NATURE PORTFOLIO in the United Kingdom, this journal has established itself as a vital resource within the fields of Aging and Geriatrics and Gerontology, proudly holding a prestigious Q1 ranking in both categories as of 2023. With an impressive Scopus ranking, placing it in the top 10 for Geriatrics and Gerontology, and the top 9 for Aging, the journal is committed to disseminating high-quality, peer-reviewed research that offers innovative insights and fosters collaboration among researchers and practitioners. Since its inception in 2015, npj Aging and Mechanisms of Disease has embraced the open-access model, ensuring that groundbreaking findings are freely available to all, thereby promoting widespread knowledge-sharing within the scientific community. This journal serves as an essential platform for those seeking to explore the complex interplay of genetic, molecular, and environmental factors that influence aging and its associated challenges.

EXPERIMENTAL CELL RESEARCH

Pioneering Insights into Cellular Dynamics
Publisher: ELSEVIER INCISSN: 0014-4827Frequency: 20 issues/year

EXPERIMENTAL CELL RESEARCH is a highly respected journal published by Elsevier Inc, specializing in the dynamic and ever-evolving field of Cell Biology. With an impact factor positioned in the Q2 quartile for 2023, it ranks at the 124th position out of 285 in the Scopus Ranks, indicating a solid reputation among peers in the domains of biochemistry, genetics, and molecular biology. Since its inception in 1950, the journal has contributed significantly to the dissemination of groundbreaking research, providing a platform for studies that explore the nuances of cellular mechanisms, processes, and experimental methodologies. Although the journal currently does not offer open access, its commitment to high-quality, peer-reviewed research continues to attract submissions from leading scientists and scholars across the globe. Researchers, professionals, and students alike will find this journal an invaluable resource for keeping abreast of current developments and innovative breakthroughs in cellular science.

Advances in Gerontology

Connecting Scholars to the Science of Aging
Publisher: PLEIADES PUBLISHING INCISSN: 2079-0570Frequency: 4 issues/year

Advances in Gerontology is a pivotal academic journal dedicated to the field of gerontology, published by PLEIADES PUBLISHING INC. With its ISSN 2079-0570 and E-ISSN 2079-0589, this journal serves as an essential platform for researchers, healthcare professionals, and students focused on aging and related health issues. Although currently not an open-access journal, it aspires to enrich the scholarly community by disseminating high-quality research from 2011 through 2024. The journal is recognized in the lower quartile of its category, ranking Q4 in both Geriatrics and Gerontology, reflecting its commitment to addressing emerging topics in the aging population despite its lower visibility in the competitive landscape. As it continues to explore critical areas in gerontology, Advances in Gerontology invites contributions that advance knowledge, foster understanding, and inform practices within this essential field of study.

Cellular and Molecular Gastroenterology and Hepatology

Empowering healthcare through open access knowledge.
Publisher: ELSEVIER INCISSN: 2352-345XFrequency: 12 issues/year

Cellular and Molecular Gastroenterology and Hepatology, published by Elsevier Inc, is a premier Open Access journal dedicated to advancing the understanding and treatment of gastrointestinal and liver diseases. Since its inception in 2015, this journal has established itself as a leading publication within its field, boasting impressive metrics with a 2023 Q1 ranking in both Gastroenterology and Hepatology. It ranks #10 out of 167 in Gastroenterology and #11 out of 82 in Hepatology on Scopus, placing it in the 94th and 87th percentiles, respectively. This journal aims to disseminate high-quality, peer-reviewed research that fosters innovative solutions for clinical challenges, making it an invaluable resource for researchers, healthcare professionals, and students alike. With open access, all published content is readily available to a global audience, ensuring that critical findings in cellular and molecular biology related to gastroenterology and hepatology reach those who can benefit the most from the latest advances in the field. For more information, please visit us at our address in San Diego, CA, or explore our articles online.

Aging Brain

Fostering Innovation in Gerontology and Neuroscience
Publisher: ELSEVIERISSN: Frequency: 1 issue/year

Aging Brain is a premier Open Access journal published by Elsevier, dedicated to advancing the understanding of the neurobiological changes associated with aging. Since its commencement in 2021, this journal has been pivotal in disseminating high-quality research that explores the intricate relationships between aging and cognitive functions, neurological disorders, and overall brain health. With a notable commitment to open accessibility, Aging Brain ensures that vital findings are available to a global audience, fostering collaboration and innovation in the field. Researchers, healthcare professionals, and students alike will find a rich repository of cutting-edge studies, reviews, and insights aimed at addressing the complexities of the aging brain. The journal stands as an influential platform for those passionate about enhancing the quality of life for the aging population, making it a valuable resource in gerontology and neuroscience.

REJUVENATION RESEARCH

Revolutionizing Perspectives on Aging and Renewal
Publisher: MARY ANN LIEBERT, INCISSN: 1549-1684Frequency: 6 issues/year

Rejuvenation Research is a premier journal dedicated to the advancing field of gerontology and aging research, published by Mary Ann Liebert, Inc. Established in 2000, the journal serves as a pivotal platform for the dissemination of scholarly articles that explore the complex mechanisms of aging and innovative approaches to rejuvenation. With an impact factor reflective of its robust scholarly contributions, the journal currently holds a Q4 ranking in Aging and a Q3 ranking in Geriatrics and Gerontology, showcasing its relevance in the academic community. This periodic publication, welcoming open access submissions, invites researchers, professionals, and students alike to engage with cutting-edge findings that could shape future geriatric practices and enhance quality of life. The journal underscores the importance of interdisciplinary collaboration, encouraging explorations that intersect with biochemistry, genetics, and other vital areas of study. Through its ongoing commitment to high-quality research, Rejuvenation Research remains a critical resource for understanding the biological underpinnings of aging and the strategies to mitigate its effects.

Current Vascular Pharmacology

Innovating Drug Development for Cardiovascular Care
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1570-1611Frequency: 6 issues/year

Current Vascular Pharmacology is a premier academic journal published by Bentham Science Publications Ltd, focusing on the intersection of pharmacology and cardiovascular medicine. With an impact factor that reflects its significance in the field, this journal ranks in the Q1 category for both Pharmacology and Cardiology, showcasing its dedication to high-quality research. Its Scopus ranks place it in the top percentile of its categories, highlighting its influence among scholars and practitioners alike. Issued since 2003 and continuing through 2024, Current Vascular Pharmacology aims to disseminate cutting-edge findings and foster knowledge exchange among researchers, professionals, and students engaged in cardiovascular pharmacology. Despite being a subscription-based journal, it remains a vital resource for those seeking the latest advancements in drug development and therapeutic interventions for vascular diseases. Located in the United Arab Emirates, the journal serves as an essential platform for global discourse on vascular health.

Aging-US

Bridging Science and Health in Aging Studies
Publisher: IMPACT JOURNALS LLCISSN: 1945-4589Frequency: 24 issues/year

Aging-US is a premier peer-reviewed journal dedicated to advancing the field of aging research and cell biology. Published by IMPACT JOURNALS LLC, this journal serves as a vital resource for researchers and professionals exploring the biological mechanisms of aging and their implications for health and disease. With a commendable impact factor reflected in its 2023 Scopus rankings, where it stands at Rank #10/38 in the category of Aging and Rank #63/285 in Cell Biology, Aging-US exemplifies rigorous scientific excellence. Its open access policy enhances accessibility, fostering a wider dissemination of knowledge in both academic and clinical settings. Spanning from 2009 to 2024, the journal provides a platform for groundbreaking studies and innovative methodologies, ensuring that it remains at the forefront of the dynamic conversations surrounding aging and cellular biology. Engage with Aging-US to contribute to the evolving narratives of longevity and cellular health.

CELL CYCLE

Exploring the Dynamics of Cell Proliferation.
Publisher: TAYLOR & FRANCIS INCISSN: 1538-4101Frequency: 24 issues/year

CELL CYCLE, an esteemed journal published by Taylor & Francis Inc., stands at the forefront of biological research, focusing on the intricate mechanisms of cell proliferation, molecular biology, and developmental biology. With an ISSN of 1538-4101 and an E-ISSN of 1551-4005, this journal has established its influence in the field with a commendable impact factor reflecting its rigorous peer-review process and high-quality publications. Notably, in 2023, it achieved a Q1 ranking in Medicine (miscellaneous) and a Q2 ranking in both Cell Biology and Developmental Biology, marking its vital role in advancing scientific understanding and innovation. Operating within a converged framework from 2002 to 2024, CELL CYCLE caters to a diverse audience of researchers, professionals, and students eager to explore contemporary findings and emerging trends. The journal's objective is to disseminate groundbreaking research that enhances our understanding of cellular mechanisms, fostering collaboration and innovation. Although not an open-access journal, it remains a premier source for those engaged in cell cycle research, and its contributions have significant implications for fields such as healthcare, biotechnology, and genetics.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Elevating knowledge in cellular and molecular lung physiology.
Publisher: AMER PHYSIOLOGICAL SOCISSN: 1040-0605Frequency: 12 issues/year

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, published by the American Physiological Society, stands as a prominent peer-reviewed journal dedicated to advancing the field of lung cellular and molecular physiology. With an impressive impact factor, the journal serves as a crucial platform for disseminating high-quality research focused on the intricate mechanisms underlying pulmonary function and disease. Established in 1989, this journal has consistently ranked within the top quartiles across various categories, including Q1 in Physiology and Pulmonary and Respiratory Medicine, highlighting its significance in the scientific community. The journal covers a wide scope of topics pertinent to cell biology and physiology, catering to the needs of researchers, professionals, and students seeking to explore and contribute to this vital area of study. Although currently not offering open access, it provides comprehensive access options for subscribers, ensuring that vital research is communicated effectively to the global scientific community. With a commitment to fostering innovation and inspiring future studies, the AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY remains an essential resource for those engaged in lung research.